skip to Main Content

Discipline: Reumatologie


Reumatologen gaan de strijd aan met het volledige spectrum van reumatologische aandoeningen

Qua behandelingsopties onderging reumatologie als discipline een ware revolutie in de voorbije twee decennia. De heterogeniteit van reumatische aandoeningen laat…

Actuele behandelingen bij reumatoïde artritis

De afgelopen jaren zijn de behandelingsmogelijkheden bij reumatoïde artritis (RA) expansief toegenomen. We onderscheiden Disease Modifying Antirheumatic Drugs (DMARDs) en…


Pitfalls in the detection of myositis specific antibodies by lineblot in clinically suspected idiopathic inflammatory myopathy.

Clin Exp Rheumatol. 2019 Jul 4.

Idiopathic inflammatory myopathies: narrative review of unmet needs in clinical practice guidelines.

RMD Open. 2019 Feb 26;4(Suppl 1):e000784. doi: 10.1136/rmdopen-2018-000784. eCollection 2018. Review.

Autoantibodies in idiopathic inflammatory myopathies: Clinical associations and laboratory evaluation by mono- and multispecific immunoassays.

Autoimmun Rev. 2019 Mar;18(3):293-305. doi: 10.1016/j.autrev.2018.10.004. Epub 2019 Jan 11. Review.

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients.


Nat Commun. 2019 Jan 2;10(1):9. doi: 10.1038/s41467-018-07911-6.

Correlative imaging in crowned dens syndrome.

Clin Nucl Med. 2007 Nov;32(11):854-7. PubMed PMID: 18075419.

Anakinra in resistant gout: a case report.

Acta Clin Belg. 2016 Oct 7:1-3. [Epub ahead of print] PubMed PMID: 27712511.

Assessment of sensitivity to change of the European Scleroderma Study Group activity index.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):148-151. PubMed PMID: 27463733.

Disease activity indices in systemic sclerosis: a systematic literature review.

Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):186-192. Review. PubMed PMID: 27385265.

EULAR Study Group on Microcirculation in Rheumatic Diseases. Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis.

Microcirculation. 2016 Jul;23(5):364-72. doi: 10.1111/micc.12281. Review. PubMed PMID: 27086648.

Six-minute walk test in systemic sclerosis: A systematic review and meta-analysis.

Int J Cardiol. 2016 Jun 1;212:265-73. doi: 10.1016/j.ijcard.2016.03.084. PubMed PMID: 27057932.

Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study.

J Rheumatol. 2016 May;43(5):995-6. doi: 10.3899/jrheum.151018. PubMed PMID:27134280.

The heart and pulmonary arterial hypertension in systemic sclerosis.

Acta Clin Belg. 2016 Feb;71(1):1-18. doi: 10.1080/17843286.2015.1108538. PubMed PMID: 27075793.

IgG4-related disease: The utility of (18)F-FDG PET/CT in diagnosis and treatment.

Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:155-9. PubMed PMID: 26672716.

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis.

J Rheumatol. 2013 Dec;40(12):2023-8. doi: 10.3899/jrheum.130528. PubMed PMID: 24128778.

Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement.

J Rheumatol. 2013 Jan;40(1):52-7. doi: 10.3899/jrheum.120778. PubMed PMID: 23118116.

Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement?

Ann Rheum Dis. 2012 Oct;71(10):1636-9. doi: 10.1136/annrheumdis-2011-200780. Epub


The impact of temperature on the evaluation of myositis specific antibodies by lineblot.


Fast track algorithm: how to differentiate a scleroderma pattern from a non-scleroderma pattern.


Case report.


20th Belgian Congres on Rheumatology. Quiz.


Rare cases of bone fragility or disorders (case reports).

La Hulpe

Assessment of Sensitivity to Change of the Disease Activity Score (DAS) in Systemic Sclerosis (SSc).


Four years follow-up of an open-label pilot study of treatment with rituximab in patients with early, diffuse cutaneous systemic sclerosis.


Two years follow-up results of a multicenter, open-label pilot study with rituximab in patients with early, diffuse cutaneous systemic sclerosis.


Stabilisation of microcirculation in patients with early systemic sclerosis with diffuse skin involvement treated with rituximab.

Oostende + San Diego

Synovial fluid derived invariant Natural Killer T cells in chronic arthritides show an increased Programmed Death-1 expression and anerghic phenotype.

La Hulpe

Two years follow-up results of an open pilot study of fixed repeated treatment with rituximab in patients with “early” systemic sclerosis with diffuse skin involvement.

Antwerpen + Chicago
Back To Top